A pulmonologist describes how using an esophageal balloon can provide a more precise diagnosis and hemodynamic classification of pulmonary hypertension.
Invasive cardiopulmonary exercise testing helps uncover the true cause of dyspnea in a 51-year-old man.
Compared with placebo, inhaled treprostinil was associated with lower risk of clinical worsening and fewer exacerbations of underlying lung disease during a 16-week treatment period.
Cleveland Clinic pulmonary hypertension and congenital heart disease specialists sought to address an unmet clinical need by combining their expertise.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
While pulmonary artery catheterization is the gold standard to diagnose pulmonary hypertension, it has limitations. A Cleveland Clinic pulmonologist discusses the strategies his lab is using to better understand cardiopulmonary hemodynamics and more precisely characterize the type of pulmonary hypertension.
Approved vasodilation therapies generally don’t improve function in patients with pulmonary hypertension associated with connective tissue disease. The Catalyst study explores the use of bardoxolone in these patients.
Since multiple conditions can mimic components of PH, the clinician should think about the patient’s total clinical condition before diagnosing and categorizing it. Proper evaluation and etiologic definition are crucial to providing the appropriate therapy and prognosis.
Since multiple conditions can mimic components of PAH, the clinician should think about the patient’s total clinical condition before diagnosing and categorizing it. Proper evaluation and etiologic definition are crucial to providing the appropriate therapy.
Cleveland Clinic research finds that chronic kidney disease is widely prevalent in patients with pulmonary hypertension, and that lower levels of kidney function are associated with an increased risk of death.
A Cleveland Clinic study to determine the prevalence of pulmonary hypertension in patients with inflammatory myopathies (IM) seems to indicate that routine screening of IM patients may be worthwhile.